182 related articles for article (PubMed ID: 35210426)
1. Stathmin 1 is a biomarker for diagnosis of microvascular invasion to predict prognosis of early hepatocellular carcinoma.
Cai Y; Fu Y; Liu C; Wang X; You P; Li X; Song Y; Mu X; Fang T; Yang Y; Gu Y; Zhang H; He Z
Cell Death Dis; 2022 Feb; 13(2):176. PubMed ID: 35210426
[TBL] [Abstract][Full Text] [Related]
2. Stathmin1 overexpression associated with polyploidy, tumor-cell invasion, early recurrence, and poor prognosis in human hepatoma.
Hsieh SY; Huang SF; Yu MC; Yeh TS; Chen TC; Lin YJ; Chang CJ; Sung CM; Lee YL; Hsu CY
Mol Carcinog; 2010 May; 49(5):476-87. PubMed ID: 20232364
[TBL] [Abstract][Full Text] [Related]
3. The E2F transcription factor 1 transactives stathmin 1 in hepatocellular carcinoma.
Chen YL; Uen YH; Li CF; Horng KC; Chen LR; Wu WR; Tseng HY; Huang HY; Wu LC; Shiue YL
Ann Surg Oncol; 2013 Nov; 20(12):4041-54. PubMed ID: 22911364
[TBL] [Abstract][Full Text] [Related]
4. STMN1 as a novel prognostic biomarker in HCC correlating with immune infiltrates and methylation.
Zhang ED; Li C; Fang Y; Li N; Xiao Z; Chen C; Wei B; Wang H; Xie J; Miao Y; Zeng Z; Huang H
World J Surg Oncol; 2022 Sep; 20(1):301. PubMed ID: 36127700
[TBL] [Abstract][Full Text] [Related]
5.
Imura S; Yamada S; Saito YU; Iwahashi S; Arakawa Y; Ikemoto T; Morine Y; Utsunomiya T; Shimada M
Anticancer Res; 2017 Oct; 37(10):5877-5883. PubMed ID: 28982915
[TBL] [Abstract][Full Text] [Related]
6. An Eastern Hepatobiliary Surgery Hospital Microvascular Invasion Scoring System in Predicting Prognosis of Patients with Hepatocellular Carcinoma and Microvascular Invasion After R0 Liver Resection: A Large-Scale, Multicenter Study.
Zhang XP; Wang K; Wei XB; Li LQ; Sun HC; Wen TF; Chai ZT; Chen ZH; Shi J; Guo WX; Xie D; Cong WM; Wu MC; Lau WY; Cheng SQ
Oncologist; 2019 Dec; 24(12):e1476-e1488. PubMed ID: 31138726
[TBL] [Abstract][Full Text] [Related]
7. Infiltrative Vessel Co-optive Growth Pattern Induced by IQGAP3 Overexpression Promotes Microvascular Invasion in Hepatocellular Carcinoma.
Tang M; Zhang S; Yang M; Feng R; Lin J; Chen X; Xu Y; Yu R; Liao X; Li Z; Li X; Li M; Zhang Q; Chen S; Qian W; Liu Y; Song L; Li J
Clin Cancer Res; 2024 May; 30(10):2206-2224. PubMed ID: 38470497
[TBL] [Abstract][Full Text] [Related]
8. A standardized pathological proposal for evaluating microvascular invasion of hepatocellular carcinoma: a multicenter study by LCPGC.
Sheng X; Ji Y; Ren GP; Lu CL; Yun JP; Chen LH; Meng B; Qu LJ; Duan GJ; Sun Q; Ye XQ; Li SS; Yang J; Liao B; Wang ZB; Zhou JH; Sun Y; Qiu XS; Wang L; Li ZS; Chen J; Xia CY; He S; Li CY; Xu EW; Geng JS; Pan C; Kuang D; Qin R; Guan HW; Wang ZD; Li LX; Zhang X; Wang H; Zhao Q; Wei B; Zhang WJ; Ling SP; Du X; Cong WM;
Hepatol Int; 2020 Dec; 14(6):1034-1047. PubMed ID: 33369707
[TBL] [Abstract][Full Text] [Related]
9. S100P as a novel biomarker of microvascular invasion and portal vein tumor thrombus in hepatocellular carcinoma.
Qi LN; Ma L; Wu FX; Chen YY; Xing WT; Jiang ZJ; Zhong JH; Chen ZS; Gong WF; Ye JZ; Li HH; Shang JJ; Xiang BD; Li LQ
Hepatol Int; 2021 Feb; 15(1):114-126. PubMed ID: 33495903
[TBL] [Abstract][Full Text] [Related]
10. STMN1 upregulation mediates hepatocellular carcinoma and hepatic stellate cell crosstalk to aggravate cancer by triggering the MET pathway.
Zhang R; Gao X; Zuo J; Hu B; Yang J; Zhao J; Chen J
Cancer Sci; 2020 Feb; 111(2):406-417. PubMed ID: 31785057
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of gamma-glutamyl transpeptidase to lymphocyte count ratio in hepatocellular carcinoma patients with microvascular invasion.
Zhang H; Zhou Y; Li Y; Qin W; Zi Y; Liu Y; Qiu X; Xu H; Liao W; Huang Z
BMC Cancer; 2020 Feb; 20(1):132. PubMed ID: 32070301
[TBL] [Abstract][Full Text] [Related]
12. A predictive and prognostic model for hepatocellular carcinoma with microvascular invasion based TCGA database genomics.
Wang J; Ding ZW; Chen K; Liu YZ; Li N; Hu MG
BMC Cancer; 2021 Dec; 21(1):1337. PubMed ID: 34911488
[TBL] [Abstract][Full Text] [Related]
13. Image-matching digital macro-slide-a novel pathological examination method for microvascular invasion detection in hepatocellular carcinoma.
Yu HM; Wang K; Feng JK; Lu L; Qin YC; Cheng YQ; Guo WX; Shi J; Cong WM; Lau WY; Dong H; Cheng SQ
Hepatol Int; 2022 Apr; 16(2):381-395. PubMed ID: 35294742
[TBL] [Abstract][Full Text] [Related]
14. The circular RNA ciRS-7 (Cdr1as) acts as a risk factor of hepatic microvascular invasion in hepatocellular carcinoma.
Xu L; Zhang M; Zheng X; Yi P; Lan C; Xu M
J Cancer Res Clin Oncol; 2017 Jan; 143(1):17-27. PubMed ID: 27614453
[TBL] [Abstract][Full Text] [Related]
15. A new horizon in risk stratification of hepatocellular carcinoma by integrating vessels that encapsulate tumor clusters and microvascular invasion.
Lu L; Wei W; Huang C; Li S; Zhong C; Wang J; Yu W; Zhang Y; Chen M; Ling Y; Guo R
Hepatol Int; 2021 Jun; 15(3):651-662. PubMed ID: 33835379
[TBL] [Abstract][Full Text] [Related]
16. Thyroid hormone suppresses expression of stathmin and associated tumor growth in hepatocellular carcinoma.
Tseng YH; Huang YH; Lin TK; Wu SM; Chi HC; Tsai CY; Tsai MM; Lin YH; Chang WC; Chang YT; Chen WJ; Lin KH
Sci Rep; 2016 Dec; 6():38756. PubMed ID: 27934948
[TBL] [Abstract][Full Text] [Related]
17. A nomogram to predict microvascular invasion in early hepatocellular carcinoma.
Li H; Li T; Hu J; Liu J
J Cancer Res Ther; 2021 Jul; 17(3):652-657. PubMed ID: 34269295
[TBL] [Abstract][Full Text] [Related]
18. Significance of presence of microvascular invasion in specimens obtained after surgical treatment of hepatocellular carcinoma.
Zhang X; Li J; Shen F; Lau WY
J Gastroenterol Hepatol; 2018 Feb; 33(2):347-354. PubMed ID: 28589639
[TBL] [Abstract][Full Text] [Related]
19. RNA sequencing reveals the long noncoding RNA and mRNA profiles and identifies long non-coding RNA TSPAN12 as a potential microvascular invasion-related biomarker in hepatocellular carcinoma.
Lu J; Li B; Xiong X; Cheng N
Biomed Pharmacother; 2020 Jun; 126():110111. PubMed ID: 32222644
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.
Ye JZ; Chen JZ; Li ZH; Bai T; Chen J; Zhu SL; Li LQ; Wu FX
World J Gastroenterol; 2017 Nov; 23(41):7415-7424. PubMed ID: 29151695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
